WO2023142797A1 - Preparation process for sulfonic acid-containing compound - Google Patents
Preparation process for sulfonic acid-containing compound Download PDFInfo
- Publication number
- WO2023142797A1 WO2023142797A1 PCT/CN2022/140658 CN2022140658W WO2023142797A1 WO 2023142797 A1 WO2023142797 A1 WO 2023142797A1 CN 2022140658 W CN2022140658 W CN 2022140658W WO 2023142797 A1 WO2023142797 A1 WO 2023142797A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- compound
- sulfonic acid
- acid group
- reaction
- formula
- Prior art date
Links
- 238000002360 preparation method Methods 0.000 title claims abstract description 109
- 150000001875 compounds Chemical class 0.000 title claims abstract description 69
- LSNNMFCWUKXFEE-UHFFFAOYSA-M Bisulfite Chemical compound OS([O-])=O LSNNMFCWUKXFEE-UHFFFAOYSA-M 0.000 title abstract description 7
- 238000006243 chemical reaction Methods 0.000 claims abstract description 73
- 239000003153 chemical reaction reagent Substances 0.000 claims abstract description 41
- 150000003839 salts Chemical class 0.000 claims abstract description 35
- 229940125904 compound 1 Drugs 0.000 claims abstract description 34
- 229940126214 compound 3 Drugs 0.000 claims abstract description 33
- 229940125782 compound 2 Drugs 0.000 claims abstract description 32
- 239000012043 crude product Substances 0.000 claims abstract description 25
- 238000000746 purification Methods 0.000 claims abstract description 20
- 230000020477 pH reduction Effects 0.000 claims abstract description 5
- 125000000542 sulfonic acid group Chemical group 0.000 claims description 54
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 30
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 30
- 239000002904 solvent Chemical class 0.000 claims description 28
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 claims description 27
- 239000007810 chemical reaction solvent Substances 0.000 claims description 22
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 claims description 21
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 claims description 20
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 claims description 18
- 230000035484 reaction time Effects 0.000 claims description 18
- IHPYMWDTONKSCO-UHFFFAOYSA-N 2,2'-piperazine-1,4-diylbisethanesulfonic acid Chemical compound OS(=O)(=O)CCN1CCN(CCS(O)(=O)=O)CC1 IHPYMWDTONKSCO-UHFFFAOYSA-N 0.000 claims description 16
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims description 16
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 claims description 16
- JKMHFZQWWAIEOD-UHFFFAOYSA-N 2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid Chemical compound OCC[NH+]1CCN(CCS([O-])(=O)=O)CC1 JKMHFZQWWAIEOD-UHFFFAOYSA-N 0.000 claims description 13
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 claims description 13
- HNXGGWNCFXZSAI-UHFFFAOYSA-N 2-morpholin-2-ylethanesulfonic acid Chemical compound OS(=O)(=O)CCC1CNCCO1 HNXGGWNCFXZSAI-UHFFFAOYSA-N 0.000 claims description 10
- OIFBSDVPJOWBCH-UHFFFAOYSA-N Diethyl carbonate Chemical compound CCOC(=O)OCC OIFBSDVPJOWBCH-UHFFFAOYSA-N 0.000 claims description 10
- IEJIGPNLZYLLBP-UHFFFAOYSA-N dimethyl carbonate Chemical compound COC(=O)OC IEJIGPNLZYLLBP-UHFFFAOYSA-N 0.000 claims description 9
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 claims description 8
- BDHFUVZGWQCTTF-UHFFFAOYSA-M sulfonate Chemical compound [O-]S(=O)=O BDHFUVZGWQCTTF-UHFFFAOYSA-M 0.000 claims description 8
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 claims description 8
- AANFEFRGGILKTJ-UHFFFAOYSA-N 3-morpholin-3-ylpropane-1-sulfonic acid Chemical compound OS(=O)(=O)CCCC1COCCN1 AANFEFRGGILKTJ-UHFFFAOYSA-N 0.000 claims description 6
- CCIVGXIOQKPBKL-UHFFFAOYSA-N ethanesulfonic acid Chemical compound CCS(O)(=O)=O CCIVGXIOQKPBKL-UHFFFAOYSA-N 0.000 claims description 6
- 125000005842 heteroatom Chemical group 0.000 claims description 6
- 125000001183 hydrocarbyl group Chemical group 0.000 claims description 6
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 4
- 229920006395 saturated elastomer Polymers 0.000 claims description 4
- 159000000000 sodium salts Chemical class 0.000 claims description 4
- 239000012752 auxiliary agent Substances 0.000 claims description 2
- 239000003054 catalyst Substances 0.000 claims description 2
- 239000007789 gas Substances 0.000 claims description 2
- 150000004677 hydrates Chemical class 0.000 claims description 2
- 239000012433 hydrogen halide Substances 0.000 claims description 2
- 229910000039 hydrogen halide Inorganic materials 0.000 claims description 2
- 229910052751 metal Inorganic materials 0.000 claims description 2
- 239000002243 precursor Substances 0.000 claims description 2
- 238000010926 purge Methods 0.000 claims description 2
- 239000000047 product Substances 0.000 abstract description 32
- 239000006177 biological buffer Substances 0.000 abstract description 7
- 239000002994 raw material Substances 0.000 abstract description 7
- 239000012535 impurity Substances 0.000 abstract description 6
- 230000015572 biosynthetic process Effects 0.000 abstract description 4
- 238000003786 synthesis reaction Methods 0.000 abstract description 3
- 238000009776 industrial production Methods 0.000 abstract 1
- 238000005481 NMR spectroscopy Methods 0.000 description 18
- 238000003756 stirring Methods 0.000 description 18
- 239000000243 solution Substances 0.000 description 11
- -1 MOPS Chemical compound 0.000 description 9
- 238000012512 characterization method Methods 0.000 description 8
- QXNVGIXVLWOKEQ-UHFFFAOYSA-N Disodium Chemical compound [Na][Na] QXNVGIXVLWOKEQ-UHFFFAOYSA-N 0.000 description 6
- YNAVUWVOSKDBBP-UHFFFAOYSA-N Morpholine Chemical compound C1COCCN1 YNAVUWVOSKDBBP-UHFFFAOYSA-N 0.000 description 6
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- 238000004519 manufacturing process Methods 0.000 description 6
- 239000012295 chemical reaction liquid Substances 0.000 description 5
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 4
- GLUUGHFHXGJENI-UHFFFAOYSA-N Piperazine Chemical compound C1CNCCN1 GLUUGHFHXGJENI-UHFFFAOYSA-N 0.000 description 4
- 239000013078 crystal Substances 0.000 description 4
- 229960001760 dimethyl sulfoxide Drugs 0.000 description 4
- 238000005516 engineering process Methods 0.000 description 4
- 238000001953 recrystallisation Methods 0.000 description 4
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical group [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- WFCSWCVEJLETKA-UHFFFAOYSA-N 2-piperazin-1-ylethanol Chemical compound OCCN1CCNCC1 WFCSWCVEJLETKA-UHFFFAOYSA-N 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical group [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- WQDUMFSSJAZKTM-UHFFFAOYSA-N Sodium methoxide Chemical group [Na+].[O-]C WQDUMFSSJAZKTM-UHFFFAOYSA-N 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- 229960000583 acetic acid Drugs 0.000 description 2
- 230000007812 deficiency Effects 0.000 description 2
- MWFJXRUUPWIALU-UHFFFAOYSA-N ethyl ethenesulfonate Chemical compound CCOS(=O)(=O)C=C MWFJXRUUPWIALU-UHFFFAOYSA-N 0.000 description 2
- 239000012362 glacial acetic acid Substances 0.000 description 2
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical group [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 2
- KWURIFKZTJGMFD-UHFFFAOYSA-M potassium;2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonate Chemical compound [K+].OCCN1CCN(CCS([O-])(=O)=O)CC1 KWURIFKZTJGMFD-UHFFFAOYSA-M 0.000 description 2
- KCXFHTAICRTXLI-UHFFFAOYSA-N propane-1-sulfonic acid Chemical compound CCCS(O)(=O)=O KCXFHTAICRTXLI-UHFFFAOYSA-N 0.000 description 2
- FUOMAVUUVFKRCF-UHFFFAOYSA-N propyl ethenesulfonate Chemical compound CCCOS(=O)(=O)C=C FUOMAVUUVFKRCF-UHFFFAOYSA-N 0.000 description 2
- XRZSXZKAAVJHQX-UHFFFAOYSA-M sodium;ethanesulfonate;2-piperazin-1-ylethanol Chemical compound [Na+].CCS([O-])(=O)=O.OCCN1CCNCC1 XRZSXZKAAVJHQX-UHFFFAOYSA-M 0.000 description 2
- NPAWNPCNZAPTKA-UHFFFAOYSA-M sodium;propane-1-sulfonate Chemical compound [Na+].CCCS([O-])(=O)=O NPAWNPCNZAPTKA-UHFFFAOYSA-M 0.000 description 2
- WGCYRFWNGRMRJA-UHFFFAOYSA-N 1-ethylpiperazine Chemical compound CCN1CCNCC1 WGCYRFWNGRMRJA-UHFFFAOYSA-N 0.000 description 1
- NLOGSHMIAWCODV-UHFFFAOYSA-N 2-piperazin-4-ium-1-ylethanesulfonate Chemical class OS(=O)(=O)CCN1CCNCC1 NLOGSHMIAWCODV-UHFFFAOYSA-N 0.000 description 1
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical group [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 1
- 239000006173 Good's buffer Substances 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 1
- 206010067482 No adverse event Diseases 0.000 description 1
- UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical group [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 description 1
- 238000002479 acid--base titration Methods 0.000 description 1
- 235000011114 ammonium hydroxide Nutrition 0.000 description 1
- XZAVPVVTKGFNQK-UHFFFAOYSA-N azane;ethanesulfonic acid Chemical compound [NH4+].CCS([O-])(=O)=O XZAVPVVTKGFNQK-UHFFFAOYSA-N 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 239000006172 buffering agent Substances 0.000 description 1
- 230000003139 buffering effect Effects 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 238000010612 desalination reaction Methods 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- CCIVGXIOQKPBKL-UHFFFAOYSA-M ethanesulfonate Chemical compound CCS([O-])(=O)=O CCIVGXIOQKPBKL-UHFFFAOYSA-M 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- STWQNIYJTAMVKL-UHFFFAOYSA-N hexyl ethenesulfonate Chemical compound CCCCCCOS(=O)(=O)C=C STWQNIYJTAMVKL-UHFFFAOYSA-N 0.000 description 1
- GPRLSGONYQIRFK-UHFFFAOYSA-N hydron Chemical compound [H+] GPRLSGONYQIRFK-UHFFFAOYSA-N 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 239000003456 ion exchange resin Substances 0.000 description 1
- 229920003303 ion-exchange polymer Polymers 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 150000004702 methyl esters Chemical class 0.000 description 1
- OIGSXRLVIQGTAV-UHFFFAOYSA-N methyl ethenesulfonate Chemical class COS(=O)(=O)C=C OIGSXRLVIQGTAV-UHFFFAOYSA-N 0.000 description 1
- 239000011259 mixed solution Substances 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 229910000027 potassium carbonate Inorganic materials 0.000 description 1
- CHUPNGGCNPHUEN-UHFFFAOYSA-M potassium;ethanesulfonate Chemical compound [K+].CCS([O-])(=O)=O CHUPNGGCNPHUEN-UHFFFAOYSA-M 0.000 description 1
- 238000002390 rotary evaporation Methods 0.000 description 1
- 238000007086 side reaction Methods 0.000 description 1
- IRHWMYKYLWNHTL-UHFFFAOYSA-M sodium 2-(N-morpholino)ethanesulfonate Chemical compound [Na+].[O-]S(=O)(=O)CCN1CCOCC1 IRHWMYKYLWNHTL-UHFFFAOYSA-M 0.000 description 1
- RDZTWEVXRGYCFV-UHFFFAOYSA-M sodium 2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonate Chemical compound [Na+].OCCN1CCN(CCS([O-])(=O)=O)CC1 RDZTWEVXRGYCFV-UHFFFAOYSA-M 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- BVIXLMYIFZGRBH-UHFFFAOYSA-M sodium;2-chloroethanesulfonate Chemical compound [Na+].[O-]S(=O)(=O)CCCl BVIXLMYIFZGRBH-UHFFFAOYSA-M 0.000 description 1
- ILWRPSCZWQJDMK-UHFFFAOYSA-N triethylazanium;chloride Chemical compound Cl.CCN(CC)CC ILWRPSCZWQJDMK-UHFFFAOYSA-N 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
- C07D295/084—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
- C07D295/088—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
Definitions
- the application belongs to the technical field of synthesis of biological buffer reagents, and in particular relates to a preparation process of a compound containing a sulfonic acid group.
- Compounds containing sulfonic acid groups such as PIPES, MOPS, HEPES, MES and the corresponding sodium salts PIPES-2Na, MOPS-Na, HEPES-Na, MES-Na, are important hydrogen ion buffers, within a certain pH range It has good buffer capacity and can maintain a constant pH for a long time.
- a sulfonic acid group-containing compound contained in the culture medium at a concentration of 20 mmol/L as a buffering agent can have good buffering capacity, and the sulfonic acid group-containing compound has no toxic effect on cells.
- Chinese patent CN110683995A discloses two preparation methods of piperazineethanesulfonic acid derivatives, both of which start the reaction by preheating in the early stage of feeding, and then reheat the reaction to a certain extent to control the 2-hydroxy
- the side reaction between ethylpiperazine and sodium 2-chloroethylsulfonate makes the reaction relatively thorough; reduce the amount of NaOH solution added during the reaction, reduce the generation of NaCl in the reaction system, and subsequently pass the reaction with triethylamine
- the method of salt formation forms triethylamine hydrochloride soluble in water and ethanol, which can be directly removed from the system, reducing the desalination process using ion exchange resins; using ethanol/water mixed solution for recrystallization, effectively reducing The residue of inorganic salts is eliminated, and the purity of the final product is relatively high.
- this application aims to disclose a preparation process of a compound containing sulfonic acid groups, so that it has important industrial application value in the fields of biological buffer reagents, etc.
- the raw materials of the preparation and purification process disclosed in this application Easy to obtain, low product manufacturing cost, simple preparation method, and can realize mass production and application in large quantities.
- the first purpose of the present application is to provide a preparation process for a compound containing sulfonic acid groups.
- the preparation method is simple, the raw materials used are easy to obtain, the product manufacturing cost is low, and the product obtained is easy to prepare.
- the yield is high, and the prepared sulfonic acid group-containing compound is purified to obtain a high-purity sulfonic acid group-containing compound boutique, which meets the requirements for purity, impurity content, and cost in the field of biological buffer reagents.
- a preparation process for a compound containing a sulfonic acid group and a salt thereof comprising the following preparation steps:
- Preparation step S1 react compound 1 with compound 2 to obtain compound 3;
- Preparation step S2 react the above compound 3 with an M-containing reagent to obtain a crude product of the M-containing salt corresponding to the compound 4 containing a sulfonic acid group, and after acidification, obtain a crude product of the compound 4 containing a sulfonic acid group;
- H2C CH-Cm -2H2 (m-2) -SO2 - OR1 ;
- Y is one of O, NH, and NR;
- R is a group that is saturated or unsaturated, contains straight or branched chains, contains heteroatoms or does not contain heteroatoms, and can be terminated by one of sulfonate, hydroxyl, and sulfonate
- R 1 is one of the C 1 -C 30 hydrocarbon groups that are saturated or unsaturated, straight or branched, heteroatom-containing or non-heteroatom-free;
- M in the M-containing reagent is one of NH 4 + and metal elements;
- the corresponding M-containing salt of compound 4 containing sulfonic acid group also includes the hydrate of the corresponding M-containing salt of compound 4 containing sulfonic acid group;
- the compound 4 containing a sulfonic acid group also includes the corresponding hydrate of the compound 4 containing a sulfonic acid group.
- compound 1 has the general structure at least one of
- the compound with the general structure of formula V is reacted with the M-containing reagent to obtain the crude salt corresponding to the compound with the general structure of formula VI containing sulfonic acid groups; after the acidification reaction, the general structure is obtained as the formula
- the compound containing sulfonic acid groups of VI, or the corresponding hydrate; the general structure shown in formula VI is:
- the compound containing sulfonic acid group is piperazine-N,N'-di(2-ethanesulfonic acid), 3-morpholinepropanesulfonic acid, 4-hydroxyethylpiperazineethanesulfonic acid, 2- Morpholineethanesulfonic acid or the piperazine-N,N'-di(2-ethanesulfonic acid), 3-morpholinepropanesulfonic acid, 4-hydroxyethylpiperazineethanesulfonic acid, 2-morpholineethanesulfonic acid acid sodium salt.
- R is one of C 1 -C 30 hydrocarbon groups whose terminal is substituted by one of sulfonate, hydroxyl, and sulfonate
- Y is NC m H 2m -SO 2 -OH, NC m H 2m -OH, NC m H 2m -CO-OH.
- the M reagent is an M-containing element, an M-containing base, an M-containing oxide, a M-containing salt or their precursors, double salts, hydrates, solvent complexes, and hydrogen halide complexes. A combination of one or more than two.
- the reaction temperature is -50-200°C
- the reaction pressure is -0.05-1MPa
- the reaction time is 0.1-72 hours
- the reaction temperature is -50-200°C
- the reaction pressure is -0.05-1MPa
- the reaction time is 0.1-72 hours.
- the molar ratio of compound 1 to compound 2 is 1:(0.1-10); in the preparation step S2, the molar ratio of compound 3 to the M-containing reagent is 1:(0.1-10).
- the preparation step S1 at least one of a catalyst or an auxiliary agent is used for the reaction.
- reaction solvent A is methanol, ethanol, acetone, tetrahydrofuran, ethyl acetate, dimethyl carbonate, diethyl carbonate, diethyl ether , acetonitrile, dioxane, N,N-dimethylformamide, dimethyl sulfoxide;
- compound 3 reacts with M-containing reagent in reaction solvent B, and the reaction Solvent B is methanol, ethanol, acetone, tetrahydrofuran, ethyl acetate, dimethyl carbonate, diethyl carbonate, ether, acetonitrile, dioxane, N,N-dimethylformamide, dimethyl sulfoxide at least one of .
- purification step is also included, and the purification step is as follows:
- the purification solvent is methanol, ethanol, acetone, tetrahydrofuran, ethyl acetate, dimethyl carbonate, diethyl carbonate, ether, acetonitrile, dioxane, N,N-dimethylformamide, di One or more combinations of methyl sulfoxide.
- the present application discloses a preparation process for a compound containing sulfonic acid groups and its salt.
- the preparation method is simple, and the raw materials used are easy to obtain.
- the prepared product has the advantages of low water content and dryness, and improves the yield of the product.
- the overall The cost of the product is reduced, and it is suitable for industrialized production and is suitable for application in the fields of life science, in vitro diagnosis or medicine.
- This application is a preparation process of a compound containing sulfonic acid groups and its salt.
- the generated by-products and impurities are easy to purify and separate, so the purification process is simple, and the impurities in the product can reach high purity without going through complicated purification processes.
- high-purity sulfonic acid group-containing compound boutiques are obtained, which meet the requirements for purity, impurity content, and cost in the field of biological buffer reagents.
- the product preparation process is simplified, the product yield is high, the product purity is high, and the production and quality requirements of large-scale applications can be met.
- gauge pressure refers to the amount by which the total absolute pressure exceeds the surrounding atmospheric pressure or the pressure at a certain point in the liquid that is higher than the atmospheric pressure.
- the yield is calculated as the percentage ratio of the actual product quality to the theoretical product quality, and the theoretical product quality is calculated with the non-excessive raw materials in the reaction equation.
- Reaction temperature generally refers to the oil bath temperature of the reaction.
- the purity of the product was analyzed by acid-base titration.
- Embodiment 1 Preparation of piperazine-N, N'-bis(2-ethanesulfonic acid) disodium (PIPES-2Na)
- the preparation of piperazine-N, N'-bis(2-ethanesulfonic acid) disodium comprises the following preparation steps:
- reaction solvent 100g of compound 1, 631.6g of compound 2, and acetonitrile as the reaction solvent to a 1L dry reactor, wherein, compound 1 is piperazine, and compound 2 is ethyl vinylsulfonate; compound 1, compound The molar ratio of 2 is 1:4, the reaction temperature is 70°C, the reaction pressure is 0.1MPa (gauge pressure), and the reaction time is 4h.
- reaction temperature is 30°C
- reaction pressure is 0 MPa (gauge pressure)
- reaction time is 5 hours.
- the crude piperazine-N,N'-bis(2-ethanesulfonate) disodium obtained in the preparation step S2 was dissolved in the purification solvent diethyl carbonate, and recrystallized. Crystallize at low temperature, filter, and dry to obtain a refined compound containing sulfonic acid groups; the purity of the product is 99.8%.
- the NMR characterization data are as follows: 1 H NMR (400MHz, D 2 O): ⁇ 3.8ppm, 2.9ppm, 2.6ppm, 2.0ppm.
- Embodiment 2 Preparation of piperazine-N, N'-two (2-ethanesulfonic acid) (PIPES)
- the preparation of 3-morpholine propanesulfonic acid comprises following preparation steps:
- the NMR characterization data are as follows: 1 H NMR (400MHz, D 2 O): ⁇ 3.5ppm, 3.4ppm.
- Embodiment 3 the preparation of 3-morpholine propanesulfonate sodium (MOPS-Na)
- the preparation technology of 3-morpholine propanesulfonate sodium comprises following preparation steps:
- the crude product 3-morpholinepropanesulfonate obtained in the preparation step S2 was dissolved in the purification solvent dimethyl carbonate, recrystallized, crystallized at low temperature, filtered, and dried. A refined compound containing sulfonic acid groups is obtained; the product has a purity of 99.6%.
- the NMR characterization data are as follows: 1 H NMR (400MHz, D 2 O): ⁇ 3.8ppm, 2.9ppm, 2.6ppm, 2.0ppm.
- Embodiment 4 the preparation of 3-morpholine propanesulfonic acid (MOPS)
- the NMR characterization data are as follows: 1 H NMR (400MHz, D 2 O): ⁇ 4.2ppm, 3.9ppm, 3.6ppm, 3.4ppm, 3.3ppm, 3.1ppm, 2.3ppm.
- Embodiment 5 the preparation of 4-hydroxyethylpiperazine ethanesulfonate sodium (HEPES-Na)
- a preparation process for a compound containing sulfonic acid groups comprising the following preparation steps:
- the NMR characterization data are as follows: 1 H NMR (400MHz, D 2 O): ⁇ 3.7ppm, 3.1ppm, 2.8ppm, 2.6ppm.
- Embodiment 6 Preparation of 4-hydroxyethylpiperazineethanesulfonic acid (HEPES)
- the preparation technology of 4-hydroxyethylpiperazineethanesulfonic acid comprises following preparation steps:
- reaction solvent N,N-dimethylformamide 207.5g M-containing reagent in 1L dry reactor;
- M-containing reagent is potassium carbonate;
- Compound 3 and containing The molar ratio of M reagent is 1:4, the reaction temperature is 100°C, the reaction pressure is 0.1MPa (gauge pressure), and the reaction time is 36h.
- step S2 Dissolve the potassium 4-hydroxyethylpiperazineethanesulfonate prepared in step S2 in methanol, use dilute sulfuric acid to adjust the pH to 4-5, stir, cool and clean the crystals, filter, and dry to obtain 4-hydroxyethylpiperazineethanesulfonate Sulfonic acid, 71% yield.
- the crude product 4-hydroxyethylpiperazineethanesulfonic acid obtained in the preparation step S3 was dissolved in the purification solvent diethyl carbonate, recrystallized, crystallized under low temperature conditions, filtered, Dry to obtain fine product; the purity of 4-hydroxyethylpiperazineethanesulfonic acid product is 99.7%.
- the NMR characterization data are as follows: 1 H NMR (400MHz, D 2 O): ⁇ 4.0ppm, 3.3ppm, 3.2ppm, 3.1ppm.
- Embodiment 7 the preparation of 2-morpholineethanesulfonate potassium (MES-K)
- the preparation technology of potassium 2-morpholineethanesulfonate comprises following preparation steps:
- reaction solvent dioxane 40.3g M-containing reagent in 1L dry reactor;
- M-containing reagent is potassium hydroxide;
- the mole of compound 3 and M-containing reagent The ratio is 1:1.5, the reaction temperature is 80°C, the reaction pressure is 0.2MPa (gauge pressure), and the reaction time is 15h.
- the crude product of potassium 2-morpholineethanesulfonate obtained in the preparation step S2 was dissolved in the purification solvent diethyl carbonate, recrystallized, crystallized under low temperature conditions, filtered, and dried.
- the refined product is obtained; the purity of the 2-morpholine ethanesulfonate potassium product is 99.5%.
- the NMR characterization data are as follows: 1 H NMR (400MHz, D 2 O): ⁇ 3.8ppm, 3.2ppm, 2.9ppm, 2.7ppm.
- Embodiment 8 the preparation of 2-morpholineethanesulfonic acid (MES)
- the preparation technology of 2-morpholineethanesulfonic acid comprises following preparation steps:
- reaction solvent ethanol 57.5g M-containing reagent in 1L dry reactor;
- M-containing reagent is ammonia water (25%);
- the molar ratio of compound 3 and M-containing reagent The ratio is 1:2, the reaction temperature is 50°C, the reaction pressure is 0.1MPa (gauge pressure), and the reaction time is 12h.
- step S2 Dissolve the crude ammonium 2-morpholineethanesulfonate prepared in step S2 in ethanol, adjust the pH to 4-5 with glacial acetic acid, stir, cool and clean the crystal, filter, and dry to obtain crude 2-morpholineethanesulfonate.
- the crude 2-morpholineethanesulfonic acid obtained in the preparation step S3 was dissolved in the purification solvent dimethyl carbonate, recrystallized, crystallized at low temperature, filtered, and dried to obtain A fine product of compounds containing sulfonic acid groups; the purity of the product is 99.6%.
- the NMR characterization data are as follows: 1 H NMR (400MHz, D 2 O): ⁇ 4.2ppm, 3.9ppm, 3.6ppm, 3.4ppm, 3.3ppm.
- the sulfonic acid group-containing compound prepared in the embodiment has high purity and less impurity content, which can meet the requirements of the application field, and the product yield of the preparation method described in the application can reach up to 76%. The yield has also been improved, and the product purity can reach up to 99.9%.
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Relating to the technical field of biological buffer reagent synthesis, provided is a preparation process for a sulfonic acid-containing compound and a slat thereof, comprising the following preparation steps: reacting a compound 1 with a compound 2 to obtain a compound 3; reacting the compound 3 with an M-containing reagent to obtain a crude product of an M-containing slat corresponding to a sulfonic acid-containing compound 4; and after acidification reaction, obtaining a crude product of the sulfonic acid-containing compound 4. Finally, the high-pure sulfonic acid-containing compound 4 and the salt thereof are obtained by performing purification process on the crude products of the sulfonic acid-containing compound 4 and a salt thereof. Raw materials used in the preparation method are low in cost and simple in operation, the obtained product is high in purity and suitable for industrial production, and the obtained product can satisfy requirements of the field of biological buffers on purity, impurity content, and cost.
Description
本申请属于生物缓冲试剂合成技术领域,尤其涉及一种含磺酸基的化合物的制备工艺。The application belongs to the technical field of synthesis of biological buffer reagents, and in particular relates to a preparation process of a compound containing a sulfonic acid group.
含磺酸基的化合物,如PIPES、MOPS、HEPES、MES以及对应的钠盐PIPES-2Na、MOPS-Na、HEPES-Na、MES-Na,是重要的氢离子缓冲剂,在一定的pH范围内具有良好的缓冲能力,能较长时间维持pH恒定。一般地,培养液内含20mmol/L浓度的含磺酸基的化合物作为缓冲剂即可具有良好的缓冲能力,且含磺酸基的化合物对细胞无毒性作用。Compounds containing sulfonic acid groups, such as PIPES, MOPS, HEPES, MES and the corresponding sodium salts PIPES-2Na, MOPS-Na, HEPES-Na, MES-Na, are important hydrogen ion buffers, within a certain pH range It has good buffer capacity and can maintain a constant pH for a long time. Generally, a sulfonic acid group-containing compound contained in the culture medium at a concentration of 20 mmol/L as a buffering agent can have good buffering capacity, and the sulfonic acid group-containing compound has no toxic effect on cells.
中国专利CN110683995A,公开了两种哌嗪乙磺酸衍生物的制备方法,均是在加料前期,通过预加热引发反应,并且通过反应自热到一定程度后再进行加热的方式,控制2-羟乙基哌嗪与2-氯乙基磺酸钠的副反应,使反应进行得相对比较彻底;反应过程中减少补加NaOH溶液的量,减少反应体系中NaCl的生成,后续通过与三乙胺成盐的方式,形成可溶于水和乙醇的三乙胺盐酸盐,可以直接从体系中除去,减少了使用离子交换树脂的除盐过程;采用乙醇/水的混合溶液重结晶,有效减少了无机盐类的残留,最终得到的产品的纯度相对较高。Chinese patent CN110683995A discloses two preparation methods of piperazineethanesulfonic acid derivatives, both of which start the reaction by preheating in the early stage of feeding, and then reheat the reaction to a certain extent to control the 2-hydroxy The side reaction between ethylpiperazine and sodium 2-chloroethylsulfonate makes the reaction relatively thorough; reduce the amount of NaOH solution added during the reaction, reduce the generation of NaCl in the reaction system, and subsequently pass the reaction with triethylamine The method of salt formation forms triethylamine hydrochloride soluble in water and ethanol, which can be directly removed from the system, reducing the desalination process using ion exchange resins; using ethanol/water mixed solution for recrystallization, effectively reducing The residue of inorganic salts is eliminated, and the purity of the final product is relatively high.
但总的来说,含磺酸基的化合物中涉及钠盐产品的专利数量比较少,其中已有的专利中,制备工艺还存在多种问题:产品的原材料不易获得、制造成本高、三废多等。因此阻碍磺酸基的化合物的大规模应用,尤其是阻碍其成为生 物缓冲试剂领域的材料。But in general, the number of patents involving sodium salt products among compounds containing sulfonic acid groups is relatively small. Among the existing patents, there are still many problems in the preparation process: the raw materials of the product are not easy to obtain, the manufacturing cost is high, and there are many wastes. wait. Therefore hinder the large-scale application of the compound of sulfonic acid group, especially hinder it from becoming the material of biological buffer reagent field.
基于上述的不足与缺陷,本申请旨在公开一种含磺酸基的化合物的制备工艺,使其在生物缓冲试剂等领域具有重要的产业化应用价值,本申请公开的制备和纯化工艺的原材料易获得、产品制造成本低、制备方法简单,可以实现大批量大规模的生产及应用。Based on the above-mentioned deficiencies and defects, this application aims to disclose a preparation process of a compound containing sulfonic acid groups, so that it has important industrial application value in the fields of biological buffer reagents, etc. The raw materials of the preparation and purification process disclosed in this application Easy to obtain, low product manufacturing cost, simple preparation method, and can realize mass production and application in large quantities.
发明内容Contents of the invention
以下是对本文详细描述的主题的概述。本概述并非是为了限制权利要求的保护范围。The following is an overview of the topics described in detail in this article. This summary is not intended to limit the scope of the claims.
为了克服现有技术的不足,本申请的第一个目的在于提供一种含磺酸基的化合物的制备工艺,该制备方法简单,使用的原材料易获得、产品制造成本低,制备所得的产品的产率较高,制备所得的含磺酸基的化合物经过纯化后,得到纯度较高的含磺酸基的化合物精品,符合生物缓冲试剂领域中对其纯度、杂质含量、成本等方面的要求。In order to overcome the deficiencies in the prior art, the first purpose of the present application is to provide a preparation process for a compound containing sulfonic acid groups. The preparation method is simple, the raw materials used are easy to obtain, the product manufacturing cost is low, and the product obtained is easy to prepare. The yield is high, and the prepared sulfonic acid group-containing compound is purified to obtain a high-purity sulfonic acid group-containing compound boutique, which meets the requirements for purity, impurity content, and cost in the field of biological buffer reagents.
实现本申请的第一个目的可以通过采取如下技术方案达到:Realize that the first purpose of the present application can be achieved by taking the following technical solutions:
一种含磺酸基的化合物及其盐的制备工艺,包括如下制备步骤:A preparation process for a compound containing a sulfonic acid group and a salt thereof, comprising the following preparation steps:
制备步骤S1:将化合物1与化合物2进行反应,得到化合物3;Preparation step S1: react compound 1 with compound 2 to obtain compound 3;
制备步骤S2:将上述的化合物3与含M试剂反应,得到含磺酸基的化合物4所对应的含M盐的粗品,经酸化后,得到含磺酸基的化合物4的粗品;Preparation step S2: react the above compound 3 with an M-containing reagent to obtain a crude product of the M-containing salt corresponding to the compound 4 containing a sulfonic acid group, and after acidification, obtain a crude product of the compound 4 containing a sulfonic acid group;
其中,化合物1的结构式为式I所示通式结构:Wherein, the structural formula of compound 1 is the general structure shown in formula I:
化合物2的结构式为式II所示通式结构:The structural formula of compound 2 is the general structure shown in formula II:
H
2C=CH-C
m-2H
2(m-2)-SO
2-O-R
1;
H2C =CH-Cm -2H2 (m-2) -SO2 - OR1 ;
式IIFormula II
Y为O、NH、NR中的一种;R为饱和或不饱和、含直链或支链、含杂原子或不含杂原子、末端可被磺酸根、羟基、磺酸盐之一的基团取代的C
1-C
30烃基中的一种;R
1为饱和或不饱和、含直链或支链、含杂原子或不含杂原子的C
1-C
30烃基中的一种;m为大于或等于2的整数;当m=2时,化合物2为H
2C=CH-SO
2-OR
1;含M试剂中M为NH
4
+、金属元素中的一种;
Y is one of O, NH, and NR; R is a group that is saturated or unsaturated, contains straight or branched chains, contains heteroatoms or does not contain heteroatoms, and can be terminated by one of sulfonate, hydroxyl, and sulfonate One of the C 1 -C 30 hydrocarbon groups substituted by groups; R 1 is one of the C 1 -C 30 hydrocarbon groups that are saturated or unsaturated, straight or branched, heteroatom-containing or non-heteroatom-free; m is an integer greater than or equal to 2; when m=2, compound 2 is H 2 C=CH-SO 2 -OR 1 ; M in the M-containing reagent is one of NH 4 + and metal elements;
化合物3的结构式为式III所示通式结构:The structural formula of compound 3 is the general structure shown in formula III:
化合物4的结构式为式IV所示通式结构:The structural formula of compound 4 is the general structure shown in formula IV:
进一步的,含磺酸基的化合物4的对应的含M盐,也包括含磺酸基的化合物4的对应的含M盐的水合物;Further, the corresponding M-containing salt of compound 4 containing sulfonic acid group also includes the hydrate of the corresponding M-containing salt of compound 4 containing sulfonic acid group;
进一步的,含磺酸基的化合物4,也包括含磺酸基的化合物4对应的水合物。Further, the compound 4 containing a sulfonic acid group also includes the corresponding hydrate of the compound 4 containing a sulfonic acid group.
其中式IV所示通式结构的化合物对应的含M盐的通式结构如式IV’所示:Wherein the general formula structure corresponding to the compound of the general formula structure shown in formula IV contains M salt as shown in formula IV':
当化合物4中的Y为N-C
mH
2m-SO
2-OH时,化合物1具有通式结构
的至少一种;
When Y in compound 4 is NC m H 2m -SO 2 -OH, compound 1 has the general structure at least one of
制备步骤S1中,化合物1与化合物2反应,制备得到通式结构为式V所示的化合物;其中式V所示通式结构为:
In the preparation step S1, compound 1 is reacted with compound 2 to prepare a compound whose general structure is represented by formula V; wherein the general structure represented by formula V is:
制备步骤S2中,将通式结构为式V的化合物与含M试剂反应,得到通式结构为式VI的含磺酸基的化合物对应的盐粗品;经过酸化反应之后,得到通式结构为式VI的含磺酸基的化合物,或对应的水合物;式VI所示通式结构为:In the preparation step S2, the compound with the general structure of formula V is reacted with the M-containing reagent to obtain the crude salt corresponding to the compound with the general structure of formula VI containing sulfonic acid groups; after the acidification reaction, the general structure is obtained as the formula The compound containing sulfonic acid groups of VI, or the corresponding hydrate; the general structure shown in formula VI is:
其中式VI所示通式结构的化合物对应的含M盐的通式结构如式VI’所示:Wherein the general formula structure corresponding to the compound of general formula structure shown in formula VI contains M salt as shown in formula VI':
进一步地,所述含磺酸基的化合物为哌嗪-N,N'-二(2-乙磺酸)、3-吗啉丙磺酸、4-羟乙基哌嗪乙磺酸、2-吗啉乙磺酸或所述哌嗪-N,N'-二(2-乙磺酸)、3-吗啉丙磺 酸、4-羟乙基哌嗪乙磺酸、2-吗啉乙磺酸的钠盐。Further, the compound containing sulfonic acid group is piperazine-N,N'-di(2-ethanesulfonic acid), 3-morpholinepropanesulfonic acid, 4-hydroxyethylpiperazineethanesulfonic acid, 2- Morpholineethanesulfonic acid or the piperazine-N,N'-di(2-ethanesulfonic acid), 3-morpholinepropanesulfonic acid, 4-hydroxyethylpiperazineethanesulfonic acid, 2-morpholineethanesulfonic acid acid sodium salt.
进一步地,Y为NR时,R为末端被磺酸根、羟基、磺酸盐之一的基团取代的C
1-C
30烃基中的一种,Y为N-C
mH
2m-SO
2-OH、N-C
mH
2m-OH、N-C
mH
2m-CO-OH。
Further, when Y is NR, R is one of C 1 -C 30 hydrocarbon groups whose terminal is substituted by one of sulfonate, hydroxyl, and sulfonate, and Y is NC m H 2m -SO 2 -OH, NC m H 2m -OH, NC m H 2m -CO-OH.
进一步地,所述M试剂为含M单质、含M的碱、含M的氧化物、含M的盐或者它们的前驱体、复盐、水合物、溶剂络合物、卤化氢络合物中的一种或两种以上的组合物。Further, the M reagent is an M-containing element, an M-containing base, an M-containing oxide, a M-containing salt or their precursors, double salts, hydrates, solvent complexes, and hydrogen halide complexes. A combination of one or more than two.
进一步地,制备步骤S1中,反应温度为-50-200℃,反应压力为-0.05-1MPa,反应时间为0.1-72小时;制备步骤S2中,反应温度为-50-200℃,反应压力为-0.05-1MPa,反应时间为0.1-72小时。Further, in the preparation step S1, the reaction temperature is -50-200°C, the reaction pressure is -0.05-1MPa, and the reaction time is 0.1-72 hours; in the preparation step S2, the reaction temperature is -50-200°C, and the reaction pressure is -0.05-1MPa, the reaction time is 0.1-72 hours.
进一步地,制备步骤S1中,化合物1与化合物2的摩尔比为1:(0.1-10);制备步骤S2中,化合物3与含M试剂的摩尔比为1:(0.1-10)。Further, in the preparation step S1, the molar ratio of compound 1 to compound 2 is 1:(0.1-10); in the preparation step S2, the molar ratio of compound 3 to the M-containing reagent is 1:(0.1-10).
进一步地,制备步骤S1中使用催化剂或助剂的至少一种进行反应。Further, in the preparation step S1, at least one of a catalyst or an auxiliary agent is used for the reaction.
进一步地,制备步骤S1中,化合物1与含M试剂在反应溶剂A中反应,所述反应溶剂A为甲醇、乙醇、丙酮、四氢呋喃、乙酸乙酯、碳酸二甲酯、碳酸二乙酯、乙醚、乙腈、二氧六环、N,N-二甲基甲酰胺、二甲基亚砜中的至少一种;制备步骤S2中,化合物3与含M试剂在反应溶剂B中反应,所述反应溶剂B为甲醇、乙醇、丙酮、四氢呋喃、乙酸乙酯、碳酸二甲酯、碳酸二乙酯、乙醚、乙腈、二氧六环、N,N-二甲基甲酰胺、二甲基亚砜中的至少一种。Further, in the preparation step S1, compound 1 is reacted with an M-containing reagent in a reaction solvent A, and the reaction solvent A is methanol, ethanol, acetone, tetrahydrofuran, ethyl acetate, dimethyl carbonate, diethyl carbonate, diethyl ether , acetonitrile, dioxane, N,N-dimethylformamide, dimethyl sulfoxide; in preparation step S2, compound 3 reacts with M-containing reagent in reaction solvent B, and the reaction Solvent B is methanol, ethanol, acetone, tetrahydrofuran, ethyl acetate, dimethyl carbonate, diethyl carbonate, ether, acetonitrile, dioxane, N,N-dimethylformamide, dimethyl sulfoxide at least one of .
进一步地,还包括纯化步骤,所述纯化步骤如下:Further, a purification step is also included, and the purification step is as follows:
在干燥条件下,使用干燥密闭设备或在干燥气体吹扫下,将制备步骤S2中所得粗品的含磺酸基的化合物,或者其盐,溶于纯化溶剂中,然后进行重结晶、 过滤、干燥,得到精制的含磺酸基的化合物。Under dry conditions, using a dry airtight device or under dry gas purging, dissolve the crude product containing a sulfonic acid group, or its salt, in the purification solvent obtained in the preparation step S2, and then recrystallize, filter, and dry , to obtain refined compounds containing sulfonic acid groups.
进一步地,所述纯化溶剂为甲醇、乙醇、丙酮、四氢呋喃、乙酸乙酯、碳酸二甲酯、碳酸二乙酯、乙醚、乙腈、二氧六环、N,N-二甲基甲酰胺、二甲基亚砜中的一种或两种以上的组合物。Further, the purification solvent is methanol, ethanol, acetone, tetrahydrofuran, ethyl acetate, dimethyl carbonate, diethyl carbonate, ether, acetonitrile, dioxane, N,N-dimethylformamide, di One or more combinations of methyl sulfoxide.
相比现有技术,本申请的有益效果在于:Compared with the prior art, the beneficial effects of the present application are:
1、本申请一种含磺酸基的化合物及其盐的制备工艺,制备方法简单,使用的原材料易获得,制备所得的产品具有低水含量、干燥的优点、提高了产品的产率,整体降低了产品的成本,适合工业化生产适合于在生命科学、体外诊断或医药等领域中的应用。1. The present application discloses a preparation process for a compound containing sulfonic acid groups and its salt. The preparation method is simple, and the raw materials used are easy to obtain. The prepared product has the advantages of low water content and dryness, and improves the yield of the product. The overall The cost of the product is reduced, and it is suitable for industrialized production and is suitable for application in the fields of life science, in vitro diagnosis or medicine.
2、本申请一种含磺酸基的化合物及其盐的制备工艺,生成的副产物和杂质容易提纯和分离,因此纯化工艺简单,产品中杂质无需通过复杂的提纯工艺即能达到高纯度的实际应用标准,经过纯化后,得到纯度较高的含磺酸基的化合物精品,符合生物缓冲试剂领域中对其纯度、杂质含量、成本等方面的要求。简化了产品制备流程,使产物收率高,产品纯度高,能满足大规模应用的产量和质量上需要。2. This application is a preparation process of a compound containing sulfonic acid groups and its salt. The generated by-products and impurities are easy to purify and separate, so the purification process is simple, and the impurities in the product can reach high purity without going through complicated purification processes. According to practical application standards, after purification, high-purity sulfonic acid group-containing compound boutiques are obtained, which meet the requirements for purity, impurity content, and cost in the field of biological buffer reagents. The product preparation process is simplified, the product yield is high, the product purity is high, and the production and quality requirements of large-scale applications can be met.
在阅读并理解了详细描述后,可以明白其他方面。Other aspects will become apparent after reading and understanding the detailed description.
下面,结合具体实施方式,对本申请做进一步描述,需要说明的是,在不相冲突的前提下,以下描述的各实施例之间或各技术特征之间可以任意组合形成新的实施例。需要说明的是,其中实施例中使用的术语是为了描述特定的具体实施方案,不构成对本申请保护范围的限制。另外,本申请使用的原料一般 均为普通市售产品,因此不需要对其来源做具体限定。Hereinafter, the present application will be further described in conjunction with specific implementation methods. It should be noted that, on the premise of not conflicting, the various embodiments or technical features described below can be combined arbitrarily to form new embodiments. It should be noted that the terms used in the examples are for describing specific implementations and do not limit the protection scope of the present application. In addition, the raw materials used in this application are generally commercially available products, so there is no need to specifically limit their sources.
本专利申请中提到的压力数值,如果无特殊说明,均指表压,表压指总绝对压力超过周围大气压力之数或液体中某一点高出大气压力的那部分压力。The pressure values mentioned in this patent application, unless otherwise specified, refer to gauge pressure. Gauge pressure refers to the amount by which the total absolute pressure exceeds the surrounding atmospheric pressure or the pressure at a certain point in the liquid that is higher than the atmospheric pressure.
产率,以实际的产品质量与理论的产品质量的百分比比值,理论的产品质量,以反应方程式中不过量的原料进行计算。The yield is calculated as the percentage ratio of the actual product quality to the theoretical product quality, and the theoretical product quality is calculated with the non-excessive raw materials in the reaction equation.
反应温度,如无特殊说明,一般指反应的油浴温度。Reaction temperature, unless otherwise specified, generally refers to the oil bath temperature of the reaction.
产品的纯度是通过酸碱滴定进行分析的。The purity of the product was analyzed by acid-base titration.
核磁分析测试,使用布鲁克(Bruker公司的AVANCE 400兆核磁共振波谱仪。NMR analysis test, using Bruker (Bruker's AVANCE 400 mega-NMR spectrometer.
实施例1:哌嗪-N,N'-二(2-乙磺酸)二钠(PIPES-2Na)的制备Embodiment 1: Preparation of piperazine-N, N'-bis(2-ethanesulfonic acid) disodium (PIPES-2Na)
哌嗪-N,N'-二(2-乙磺酸)二钠的制备,包括如下制备步骤:The preparation of piperazine-N, N'-bis(2-ethanesulfonic acid) disodium comprises the following preparation steps:
制备步骤S1:Preparation step S1:
在搅拌的条件下,向1L的干燥反应器中分别加入100g化合物1、631.6g化合物2,反应溶剂乙腈,其中,化合物1为哌嗪,化合物2为乙烯基磺酸乙酯;化合物1、化合物2的摩尔比为1:4,反应温度为70℃,反应压力为0.1MPa(表压),反应时间为4h。Under stirring conditions, add 100g of compound 1, 631.6g of compound 2, and acetonitrile as the reaction solvent to a 1L dry reactor, wherein, compound 1 is piperazine, and compound 2 is ethyl vinylsulfonate; compound 1, compound The molar ratio of 2 is 1:4, the reaction temperature is 70°C, the reaction pressure is 0.1MPa (gauge pressure), and the reaction time is 4h.
反应完成后降至常温,反应液减压旋转蒸发除去溶剂,浓缩,制备得到化合物3粗品。After the reaction was completed, the temperature was lowered to normal temperature, the reaction solution was rotatably evaporated under reduced pressure to remove the solvent, and then concentrated to prepare the crude compound 3.
制备步骤S2:Preparation step S2:
在搅拌的条件下,向1L的干燥反应器中加入上述100g化合物3,反应溶剂甲醇,33.5g含M试剂,其中含M试剂为氢氧化钠;化合物3与含M试剂的摩尔比为1:3,反应温度为30℃,反应压力0MPa(表压),反应时间为5h。Under the condition of stirring, add the above-mentioned 100g compound 3, reaction solvent methanol, and 33.5g M-containing reagent into a 1L dry reactor, wherein the M-containing reagent is sodium hydroxide; the molar ratio of compound 3 to the M-containing reagent is 1: 3. The reaction temperature is 30°C, the reaction pressure is 0 MPa (gauge pressure), and the reaction time is 5 hours.
反应完成后降至常温,反应液减压旋转蒸发除去溶剂,浓缩,制备得到哌嗪-N,N'-二(2-乙磺酸)二钠粗品,产率为75%。After the reaction was completed, the temperature was lowered to normal temperature, the reaction liquid was rotatably evaporated under reduced pressure to remove the solvent, and then concentrated to prepare the crude product of piperazine-N,N'-bis(2-ethanesulfonic acid) disodium with a yield of 75%.
制备步骤S3:Preparation step S3:
在干燥条件下,使用干燥密闭设备下,将制备步骤S2所得的粗品哌嗪-N,N'-二(2-乙磺酸)二钠溶于纯化溶剂碳酸二乙酯中,进行重结晶,在低温条件下结晶,过滤,干燥,得到含磺酸基的化合物精品;产品的纯度为99.8%。Under dry conditions, using dry airtight equipment, the crude piperazine-N,N'-bis(2-ethanesulfonate) disodium obtained in the preparation step S2 was dissolved in the purification solvent diethyl carbonate, and recrystallized. Crystallize at low temperature, filter, and dry to obtain a refined compound containing sulfonic acid groups; the purity of the product is 99.8%.
核磁共振表征数据如下:
1H NMR(400MHz,D
2O):δ3.8ppm,2.9ppm,2.6ppm,2.0ppm。
The NMR characterization data are as follows: 1 H NMR (400MHz, D 2 O): δ3.8ppm, 2.9ppm, 2.6ppm, 2.0ppm.
实施例2:哌嗪-N,N'-二(2-乙磺酸)(PIPES)的制备Embodiment 2: Preparation of piperazine-N, N'-two (2-ethanesulfonic acid) (PIPES)
3-吗啉丙磺酸的制备,包括如下制备步骤:The preparation of 3-morpholine propanesulfonic acid comprises following preparation steps:
制备步骤S1:Preparation step S1:
在搅拌的条件下,向1L的干燥反应器中分别加入100g化合物1、1743g化合物2,反应溶剂丙酮;其中,化合物1为哌嗪,化合物2为乙烯基磺酸丙酯;化合物1、化合物2的摩尔比为1:10,反应温度为40℃,反应压力为0.2MPa(表压),反应时间为15h。Under stirring conditions, add 100g of compound 1, 1743g of compound 2, and acetone as a reaction solvent to a 1L dry reactor; wherein, compound 1 is piperazine, and compound 2 is propyl vinylsulfonate; compound 1, compound 2 The molar ratio is 1:10, the reaction temperature is 40°C, the reaction pressure is 0.2MPa (gauge pressure), and the reaction time is 15h.
反应完成后降至常温,反应液减压旋转蒸发除去溶剂,浓缩,制备得到化 合物3粗品。After the reaction was completed, it was lowered to normal temperature, and the reaction solution was rotatably evaporated under reduced pressure to remove the solvent, and then concentrated to prepare the crude product of compound 3.
制备步骤S2:Preparation step S2:
在搅拌的条件下,向1L的干燥反应器中加入上述100g化合物3,反应溶剂四氢呋喃,21.7g含M试剂;其中含M试剂为碳酸氢钠,化合物3与含M试剂的摩尔比为1:1,反应温度为65℃,反应压力0.2MPa(表压),反应时间为1h。Under the condition of stirring, add the above-mentioned 100g compound 3, the reaction solvent tetrahydrofuran, and 21.7g M-containing reagent into a 1L dry reactor; wherein the M-containing reagent is sodium bicarbonate, and the molar ratio of compound 3 to the M-containing reagent is 1: 1. The reaction temperature is 65°C, the reaction pressure is 0.2MPa (gauge pressure), and the reaction time is 1h.
反应完成后降至常温,反应液减压旋转蒸发除去溶剂,浓缩,制备得到哌嗪-N,N'-二(2-乙磺酸)二钠粗品。After the reaction was completed, the temperature was lowered to normal temperature, the reaction solution was rotatably evaporated under reduced pressure to remove the solvent, and then concentrated to prepare a crude product of piperazine-N,N'-bis(2-ethanesulfonic acid) disodium.
制备步骤S3:Preparation step S3:
将步骤S2制备得到的哌嗪-N,N'-二(2-乙磺酸)二钠粗品溶于乙醇,使用冰乙酸调节pH为4-5,搅拌,冷却洁晶,过滤,干燥,得到哌嗪-N,N'-二(2-乙磺酸)。Dissolve the crude piperazine-N,N'-bis(2-ethanesulfonic acid) disodium prepared in step S2 in ethanol, use glacial acetic acid to adjust the pH to 4-5, stir, cool and clean the crystal, filter, and dry to obtain Piperazine-N,N'-di(2-ethanesulfonic acid).
制备步骤S4:Preparation step S4:
在干燥条件下,使用干燥密闭设备下,将制备步骤S3所得的哌嗪-N,N'-二(2-乙磺酸)溶于纯化溶剂乙醇中,在低温条件下进行重结晶,过滤,干燥,得到含磺酸基的化合物精品;哌嗪-N,N'-二(2-乙磺酸)的产率为70%,产品的纯度为99.9%。Under dry conditions, using dry airtight equipment, dissolve the piperazine-N,N'-di(2-ethanesulfonic acid) obtained in the preparation step S3 in the purification solvent ethanol, perform recrystallization under low temperature conditions, filter, After drying, the refined compound containing sulfonic acid group was obtained; the yield of piperazine-N,N'-bis(2-ethanesulfonic acid) was 70%, and the purity of the product was 99.9%.
核磁共振表征数据如下:
1H NMR(400MHz,D
2O):δ3.5ppm、3.4ppm。
The NMR characterization data are as follows: 1 H NMR (400MHz, D 2 O): δ3.5ppm, 3.4ppm.
实施例3:3-吗啉丙磺酸钠(MOPS-Na)的制备Embodiment 3: the preparation of 3-morpholine propanesulfonate sodium (MOPS-Na)
3-吗啉丙磺酸钠的制备工艺,包括如下制备步骤:The preparation technology of 3-morpholine propanesulfonate sodium comprises following preparation steps:
制备步骤S1:Preparation step S1:
在搅拌的条件下,向1L的干燥反应器中加入100g化合物1、234.2g化合物2,反应溶剂N,N-二甲基甲酰胺;其中,化合物1为吗啉,化合物2为烯丙基磺酸甲酯;化合物1、化合物2的摩尔比为1:1.5,反应温度为100℃,反应压力为0.4MPa(表压),反应时间为1h。Under stirring conditions, add 100g of compound 1, 234.2g of compound 2, and the reaction solvent N,N-dimethylformamide into a 1L dry reactor; wherein, compound 1 is morpholine, and compound 2 is allyl sulfonate Acid methyl ester; the molar ratio of compound 1 and compound 2 is 1:1.5, the reaction temperature is 100°C, the reaction pressure is 0.4MPa (gauge pressure), and the reaction time is 1h.
反应完成后降至常温,反应液减压旋转蒸发除去溶剂,浓缩,制备得到化合物3粗品。After the reaction was completed, the temperature was lowered to normal temperature, the reaction solution was rotatably evaporated under reduced pressure to remove the solvent, and then concentrated to prepare the crude compound 3.
制备步骤S2:Preparation step S2:
在搅拌的条件下,向1L的干燥反应器中加入上述100g化合物3,反应溶剂二甲基亚砜,237.7g含M试剂;其中含M试剂为碳酸钠;化合物3与含M试剂的摩尔比为1:5,反应温度为60℃,反应压力0MPa(表压),反应时间为5h。Under stirring conditions, add the above-mentioned 100g compound 3, the reaction solvent dimethyl sulfoxide, and 237.7g M-containing reagent to a 1L dry reactor; wherein the M-containing reagent is sodium carbonate; the molar ratio of compound 3 to the M-containing reagent The ratio is 1:5, the reaction temperature is 60°C, the reaction pressure is 0MPa (gauge pressure), and the reaction time is 5h.
反应完成后降至常温,反应液减压旋转蒸发除去溶剂,浓缩,制备得到3-吗啉丙磺酸钠粗品,3-吗啉丙磺酸钠粗品产率为72%。After the reaction was completed, the temperature was lowered to normal temperature, the reaction liquid was rotatably evaporated under reduced pressure to remove the solvent, and concentrated to prepare a crude product of 3-morpholine propanesulfonate, the crude product yield of 3-morpholine propanesulfonate was 72%.
制备步骤S3:Preparation step S3:
在干燥条件下,使用干燥密闭设备下,将制备步骤S2所得的粗品3-吗啉丙磺酸钠溶于纯化溶剂碳酸二甲酯中,进行重结晶,在低温条件下结晶,过滤,干燥,得到含磺酸基的化合物精品;产品的纯度为99.6%。Under dry conditions, using dry airtight equipment, the crude product 3-morpholinepropanesulfonate obtained in the preparation step S2 was dissolved in the purification solvent dimethyl carbonate, recrystallized, crystallized at low temperature, filtered, and dried. A refined compound containing sulfonic acid groups is obtained; the product has a purity of 99.6%.
核磁共振表征数据如下:
1H NMR(400MHz,D
2O):δ3.8ppm,2.9ppm,2.6ppm,2.0ppm。
The NMR characterization data are as follows: 1 H NMR (400MHz, D 2 O): δ3.8ppm, 2.9ppm, 2.6ppm, 2.0ppm.
实施例4:3-吗啉丙磺酸(MOPS)的制备Embodiment 4: the preparation of 3-morpholine propanesulfonic acid (MOPS)
将实施例3制备得到的3-吗啉丙磺酸钠粗品溶于甲醇,使用稀盐酸溶液调节pH为4-5,搅拌,冷却洁晶,过滤,干燥,得到粗品3-吗啉丙磺酸;Dissolve the crude sodium 3-morpholinepropanesulfonate prepared in Example 3 in methanol, use dilute hydrochloric acid solution to adjust the pH to 4-5, stir, cool and clean the crystal, filter, and dry to obtain the crude product 3-morpholinepropanesulfonic acid ;
在干燥条件下,使用干燥密闭设备下,将粗品3-吗啉丙磺酸溶于纯化溶剂甲醇中,进行重结晶,在低温条件下结晶,过滤,干燥,得到精品;3-吗啉丙磺酸的总产率为71%(合成以及纯化的总产率),纯度为99.6%。Under dry conditions, using dry and airtight equipment, dissolve the crude product 3-morpholine propanesulfonic acid in the purification solvent methanol, carry out recrystallization, crystallize under low temperature conditions, filter and dry to obtain the refined product; 3-morpholine propanesulfonic acid The overall yield of acid was 71% (total yield of synthesis and purification) with a purity of 99.6%.
核磁共振表征数据如下:
1H NMR(400MHz,D
2O):δ4.2ppm,3.9ppm,3.6ppm,3.4ppm,3.3ppm,3.1ppm,2.3ppm。
The NMR characterization data are as follows: 1 H NMR (400MHz, D 2 O): δ4.2ppm, 3.9ppm, 3.6ppm, 3.4ppm, 3.3ppm, 3.1ppm, 2.3ppm.
实施例5:4-羟乙基哌嗪乙磺酸钠(HEPES-Na)的制备Embodiment 5: the preparation of 4-hydroxyethylpiperazine ethanesulfonate sodium (HEPES-Na)
一种含磺酸基的化合物的制备工艺,包括如下制备步骤:A preparation process for a compound containing sulfonic acid groups, comprising the following preparation steps:
制备步骤S1:Preparation step S1:
在搅拌的条件下,向1L的干燥反应器中加入100g化合物1、147.7g化合物2,反应溶剂二氧六环;其中,化合物1为4-羟乙基哌嗪,化合物2为乙烯基磺酸正己酯;化合物1、化合物2的摩尔比为1:1,反应温度为140℃,反应压力为1MPa(表压),反应时间为24h。Under stirring conditions, add 100g of compound 1, 147.7g of compound 2, and the reaction solvent dioxane into a 1L dry reactor; wherein, compound 1 is 4-hydroxyethylpiperazine, and compound 2 is vinylsulfonic acid n-hexyl ester; the molar ratio of compound 1 and compound 2 is 1:1, the reaction temperature is 140°C, the reaction pressure is 1MPa (gauge pressure), and the reaction time is 24h.
反应完成后降至常温,反应液减压旋转蒸发除去溶剂,浓缩,制备得到化合物3粗品。After the reaction was completed, the temperature was lowered to normal temperature, the reaction solution was rotatably evaporated under reduced pressure to remove the solvent, and then concentrated to prepare the crude compound 3.
制备步骤S2:Preparation step S2:
在搅拌的条件下,向1L的干燥反应器中加入上述100g化合物3,反应溶剂碳酸二甲酯,167.5g含M试剂;其中,含M试剂为甲醇钠;化合物3与含M 试剂的摩尔比为1:10,反应温度为30℃,反应压力0MPa(表压),反应时间为24h。Under stirring conditions, add the above-mentioned 100g compound 3, the reaction solvent dimethyl carbonate, and 167.5g M-containing reagent to a 1L dry reactor; wherein, the M-containing reagent is sodium methylate; the molar ratio of compound 3 to the M-containing reagent The ratio is 1:10, the reaction temperature is 30°C, the reaction pressure is 0MPa (gauge pressure), and the reaction time is 24h.
反应完成后降至常温,反应液减压旋转蒸发除去溶剂,浓缩,制备得到4-羟乙基哌嗪乙磺酸钠粗品,4-羟乙基哌嗪乙磺酸钠粗品产率为69%。After the reaction was completed, it was lowered to normal temperature, and the reaction liquid was evaporated under reduced pressure to remove the solvent, concentrated, and the crude product of 4-hydroxyethylpiperazineethanesulfonate was prepared, and the yield of the crude product of 4-hydroxyethylpiperazineethanesulfonate was 69%. .
制备步骤S3:Preparation step S3:
在干燥条件下,使用干燥密闭设备下,将制备步骤S2所得的粗品4-羟乙基哌嗪乙磺酸钠溶于纯化溶剂碳酸二乙酯中,进行重结晶,在低温条件下结晶,过滤,干燥,得到4-羟乙基哌嗪乙磺酸钠精品;纯度为99.7%。Under dry conditions, using dry airtight equipment, dissolve the crude product sodium 4-hydroxyethylpiperazineethanesulfonate obtained in the preparation step S2 in the purification solvent diethyl carbonate, perform recrystallization, crystallize under low temperature conditions, and filter , dried to obtain 4-hydroxyethylpiperazine ethanesulfonate sodium product; the purity is 99.7%.
核磁共振表征数据如下:
1H NMR(400MHz,D
2O):δ3.7ppm,3.1ppm,2.8ppm,2.6ppm。
The NMR characterization data are as follows: 1 H NMR (400MHz, D 2 O): δ3.7ppm, 3.1ppm, 2.8ppm, 2.6ppm.
实施例6:4-羟乙基哌嗪乙磺酸(HEPES)的制备Embodiment 6: Preparation of 4-hydroxyethylpiperazineethanesulfonic acid (HEPES)
4-羟乙基哌嗪乙磺酸的制备工艺,包括如下制备步骤:The preparation technology of 4-hydroxyethylpiperazineethanesulfonic acid comprises following preparation steps:
制备步骤S1:Preparation step S1:
在搅拌的条件下,向1L的干燥反应器中加入100g化合物1、732.1g化合物2、反应溶剂乙醚;其中,化合物1为4-羟乙基哌嗪,化合物2为乙烯基磺酸乙酯;化合物1、化合物2的摩尔比为1:7,反应温度为25℃,反应压力为0MPa(表压),反应时间为72h。Under stirring conditions, add 100g of compound 1, 732.1g of compound 2, and ether as a reaction solvent into a 1L dry reactor; wherein, compound 1 is 4-hydroxyethylpiperazine, and compound 2 is ethyl vinylsulfonate; The molar ratio of compound 1 and compound 2 is 1:7, the reaction temperature is 25° C., the reaction pressure is 0 MPa (gauge pressure), and the reaction time is 72 h.
反应完成后降至常温,减压旋转蒸发除去溶剂,浓缩,制备得到化合物3粗品。After the reaction was completed, it was lowered to normal temperature, the solvent was removed by rotary evaporation under reduced pressure, and concentrated to prepare the crude compound 3.
制备步骤S2:Preparation step S2:
在搅拌的条件下,向1L的干燥反应器中加入上述100g化合物3,反应溶剂N,N-二甲基甲酰胺,207.5g含M试剂;其中,含M试剂为碳酸钾;化合物3与含M试剂的摩尔比为1:4,反应温度为100℃,反应压力0.1MPa(表压),反应时间为36h。Under the condition of stirring, add above-mentioned 100g compound 3, reaction solvent N,N-dimethylformamide, 207.5g M-containing reagent in 1L dry reactor; Wherein, M-containing reagent is potassium carbonate; Compound 3 and containing The molar ratio of M reagent is 1:4, the reaction temperature is 100°C, the reaction pressure is 0.1MPa (gauge pressure), and the reaction time is 36h.
反应完成后降至常温,反应液减压旋转蒸发除去溶剂,浓缩,制备得到4-羟乙基哌嗪乙磺酸钾粗品。After the reaction was completed, the temperature was lowered to normal temperature, the reaction liquid was rotatably evaporated under reduced pressure to remove the solvent, and then concentrated to prepare the crude product of potassium 4-hydroxyethylpiperazineethanesulfonate.
制备步骤S3:Preparation step S3:
将步骤S2制备得到的4-羟乙基哌嗪乙磺酸钾溶于甲醇,使用稀硫酸调节pH为4-5,搅拌,冷却洁晶,过滤,干燥,得到4-羟乙基哌嗪乙磺酸,产率为71%。Dissolve the potassium 4-hydroxyethylpiperazineethanesulfonate prepared in step S2 in methanol, use dilute sulfuric acid to adjust the pH to 4-5, stir, cool and clean the crystals, filter, and dry to obtain 4-hydroxyethylpiperazineethanesulfonate Sulfonic acid, 71% yield.
制备步骤4:Preparation step 4:
在干燥条件下,使用干燥密闭设备下,将制备步骤S3所得的粗品4-羟乙基哌嗪乙磺酸溶于纯化溶剂碳酸二乙酯中,进行重结晶,在低温条件下结晶,过滤,干燥,得到精品;4-羟乙基哌嗪乙磺酸产品的纯度为99.7%。Under dry conditions, using dry airtight equipment, the crude product 4-hydroxyethylpiperazineethanesulfonic acid obtained in the preparation step S3 was dissolved in the purification solvent diethyl carbonate, recrystallized, crystallized under low temperature conditions, filtered, Dry to obtain fine product; the purity of 4-hydroxyethylpiperazineethanesulfonic acid product is 99.7%.
核磁共振表征数据如下:
1H NMR(400MHz,D
2O):δ4.0ppm,3.3ppm,3.2ppm,3.1ppm。
The NMR characterization data are as follows: 1 H NMR (400MHz, D 2 O): δ4.0ppm, 3.3ppm, 3.2ppm, 3.1ppm.
实施例7:2-吗啉乙磺酸钾(MES-K)的制备Embodiment 7: the preparation of 2-morpholineethanesulfonate potassium (MES-K)
2-吗啉乙磺酸钾的制备工艺,包括如下制备步骤:The preparation technology of potassium 2-morpholineethanesulfonate comprises following preparation steps:
制备步骤S1:Preparation step S1:
在搅拌的条件下,向1L的干燥反应器中加入100g化合物1、140g化合物2,反应溶剂N,N-二甲基甲酰胺;其中,化合物1为吗啉,化合物2为乙烯基磺酸甲酯;化合物1、化合物2的摩尔比为1:1,反应温度为25℃,反应压力为0.1MPa(表压),反应时间为54h。Under stirring conditions, add 100g of compound 1, 140g of compound 2, and the reaction solvent N,N-dimethylformamide into a 1L dry reactor; wherein, compound 1 is morpholine, and compound 2 is methyl vinylsulfonate Esters; the molar ratio of compound 1 and compound 2 is 1:1, the reaction temperature is 25°C, the reaction pressure is 0.1MPa (gauge pressure), and the reaction time is 54h.
反应完成后降至常温,反应液减压旋转蒸发除去溶剂,浓缩,制备得到化合物3粗品。After the reaction was completed, the temperature was lowered to normal temperature, the reaction solution was rotatably evaporated under reduced pressure to remove the solvent, and then concentrated to prepare the crude compound 3.
制备步骤S2:Preparation step S2:
在搅拌的条件下,向1L的干燥反应器中加入上述100g化合物3,反应溶剂二氧六环,40.3g含M试剂;其中,含M试剂为氢氧化钾;化合物3与含M试剂的摩尔比为1:1.5,反应温度为80℃,反应压力0.2MPa(表压),反应时间为15h。Under the condition of stirring, add above-mentioned 100g compound 3, reaction solvent dioxane, 40.3g M-containing reagent in 1L dry reactor; Wherein, M-containing reagent is potassium hydroxide; The mole of compound 3 and M-containing reagent The ratio is 1:1.5, the reaction temperature is 80°C, the reaction pressure is 0.2MPa (gauge pressure), and the reaction time is 15h.
反应完成后降至常温,反应液减压旋转蒸发除去溶剂,浓缩,制备得到2-吗啉乙磺酸钾的粗品,产率为76%。After the reaction was completed, the temperature was lowered to normal temperature, the reaction solution was evaporated under reduced pressure to remove the solvent, and then concentrated to prepare the crude product of potassium 2-morpholineethanesulfonate with a yield of 76%.
制备步骤S3:Preparation step S3:
在干燥条件下,使用干燥密闭设备下,将制备步骤S2所得的2-吗啉乙磺酸钾粗品溶于纯化溶剂碳酸二乙酯中,进行重结晶,在低温条件下结晶,过滤,干燥,得到精品;2-吗啉乙磺酸钾产品的纯度为99.5%。Under dry conditions, using dry airtight equipment, the crude product of potassium 2-morpholineethanesulfonate obtained in the preparation step S2 was dissolved in the purification solvent diethyl carbonate, recrystallized, crystallized under low temperature conditions, filtered, and dried. The refined product is obtained; the purity of the 2-morpholine ethanesulfonate potassium product is 99.5%.
核磁共振表征数据如下:
1H NMR(400MHz,D
2O):δ3.8ppm,3.2ppm,2.9ppm,2.7ppm。
The NMR characterization data are as follows: 1 H NMR (400MHz, D 2 O): δ3.8ppm, 3.2ppm, 2.9ppm, 2.7ppm.
实施例8:2-吗啉乙磺酸(MES)的制备Embodiment 8: the preparation of 2-morpholineethanesulfonic acid (MES)
2-吗啉乙磺酸的制备工艺,包括如下制备步骤:The preparation technology of 2-morpholineethanesulfonic acid comprises following preparation steps:
制备步骤S1:Preparation step S1:
在搅拌的条件下,向1L的干燥反应器中加入100g化合物1、258.3g化合物2,反应溶剂四氢呋喃;其中,化合物1为吗啉,化合物2为乙烯基磺酸丙酯;化合物1、化合物2的摩尔比为1:1.5,反应温度为50℃,反应压力为0.1MPa(表压),反应时间为24h。Under stirring conditions, add 100g of compound 1, 258.3g of compound 2, and the reaction solvent tetrahydrofuran into a 1L dry reactor; wherein, compound 1 is morpholine, compound 2 is propyl vinyl sulfonate; compound 1, compound 2 The molar ratio is 1:1.5, the reaction temperature is 50°C, the reaction pressure is 0.1MPa (gauge pressure), and the reaction time is 24h.
反应完成后降至常温,反应液减压旋转蒸发除去溶剂,浓缩,制备得到化合物3粗品。After the reaction was completed, the temperature was lowered to normal temperature, the reaction solution was rotatably evaporated under reduced pressure to remove the solvent, and then concentrated to prepare the crude compound 3.
制备步骤S2:Preparation step S2:
在搅拌的条件下,向1L的干燥反应器中加入上述100g化合物3,反应溶剂乙醇,57.5g含M试剂;其中,含M试剂为氨水(25%);化合物3与含M试剂的摩尔比为1:2,反应温度为50℃,反应压力0.1MPa(表压),反应时间为12h。Under the condition of stirring, add above-mentioned 100g compound 3, reaction solvent ethanol, 57.5g M-containing reagent in 1L dry reactor; Wherein, M-containing reagent is ammonia water (25%); The molar ratio of compound 3 and M-containing reagent The ratio is 1:2, the reaction temperature is 50°C, the reaction pressure is 0.1MPa (gauge pressure), and the reaction time is 12h.
反应完成后降至常温,反应液减压旋转蒸发除去溶剂,浓缩,制备得到2-吗啉乙磺酸铵粗品,产率为68%。After the reaction was completed, the temperature was lowered to normal temperature, the reaction liquid was rotatably evaporated under reduced pressure to remove the solvent, and then concentrated to prepare the crude product of 2-morpholine ammonium ethanesulfonate with a yield of 68%.
制备步骤S3:Preparation step S3:
将步骤S2制备得到的2-吗啉乙磺酸铵粗品溶于乙醇,使用冰乙酸调节pH为4-5,搅拌,冷却洁晶,过滤,干燥,得到2-吗啉乙磺酸粗品。Dissolve the crude ammonium 2-morpholineethanesulfonate prepared in step S2 in ethanol, adjust the pH to 4-5 with glacial acetic acid, stir, cool and clean the crystal, filter, and dry to obtain crude 2-morpholineethanesulfonate.
制备步骤S4:Preparation step S4:
在干燥条件下,使用干燥密闭设备下,将制备步骤S3所得的2-吗啉乙磺酸粗品溶于纯化溶剂碳酸二甲酯中,进行重结晶,在低温条件下结晶,过滤,干燥,得到含磺酸基的化合物精品;产品的纯度为99.6%。Under dry conditions, using dry airtight equipment, the crude 2-morpholineethanesulfonic acid obtained in the preparation step S3 was dissolved in the purification solvent dimethyl carbonate, recrystallized, crystallized at low temperature, filtered, and dried to obtain A fine product of compounds containing sulfonic acid groups; the purity of the product is 99.6%.
核磁共振表征数据如下:
1H NMR(400MHz,D
2O):δ4.2ppm,3.9ppm,3.6ppm,3.4ppm,3.3ppm。
The NMR characterization data are as follows: 1 H NMR (400MHz, D 2 O): δ4.2ppm, 3.9ppm, 3.6ppm, 3.4ppm, 3.3ppm.
通过上述实验看出,实施例中制备的含磺酸基的化合物的纯度高、杂质含量少,能够满足应用领域要求,而且本申请所述的制备方法的产物收率最高可达76%,产物收率也得到了提升,产物纯度最高可达到99.9%。It can be seen from the above experiments that the sulfonic acid group-containing compound prepared in the embodiment has high purity and less impurity content, which can meet the requirements of the application field, and the product yield of the preparation method described in the application can reach up to 76%. The yield has also been improved, and the product purity can reach up to 99.9%.
上述实施方式仅为本申请的优选实施方式,不能以此来限定本申请保护的范围,本领域的技术人员在本申请的基础上所做的任何非实质性的变化及替换均属于本申请所要求保护的范围。The above-mentioned implementation mode is only the preferred implementation mode of the present application, which cannot limit the protection scope of the present application. Scope of protection claimed.
Claims (12)
- 一种含磺酸基的化合物及其盐的制备工艺,其中,A preparation process for a compound containing a sulfonic acid group and a salt thereof, wherein,制备步骤S1:将化合物1与化合物2进行反应,得到化合物3;Preparation step S1: react compound 1 with compound 2 to obtain compound 3;制备步骤S2:将上述的化合物3与含M试剂反应,得到含磺酸基的化合物4所对应的含M盐的粗品;经酸化反应后,得到含磺酸基的化合物4的粗品;Preparation step S2: reacting the above-mentioned compound 3 with an M-containing reagent to obtain a crude product of the M-containing salt corresponding to the compound 4 containing a sulfonic acid group; after an acidification reaction, a crude product of the compound 4 containing a sulfonic acid group is obtained;其中,化合物1的结构式为式I所示通式结构:Wherein, the structural formula of compound 1 is the general structure shown in formula I:化合物2的结构式为式II所示通式结构:The structural formula of compound 2 is the general structure shown in formula II:H 2C=CH-C m-2H 2(m-2)-SO 2-O-R 1; H2C =CH-Cm -2H2 (m-2) -SO2 - OR1 ;式IIFormula IIY为O、NH、NR中的一种;R为饱和或不饱和、含直链或支链、含杂原子或不含杂原子、末端可被磺酸根、羟基、磺酸盐之一的基团取代的C 1-C 30烃基中的一种;R 1为饱和或不饱和、含直链或支链、含杂原子或不含杂原子的C 1-C 30烃基中的一种;m为大于或等于2的整数;当m=2时,化合物2为,H 2C=CH-SO 2-OR 1;含M试剂中M为NH 4 +、金属元素中的一种; Y is one of O, NH, and NR; R is a group that is saturated or unsaturated, contains straight or branched chains, contains heteroatoms or does not contain heteroatoms, and can be terminated by one of sulfonate, hydroxyl, and sulfonate One of the C 1 -C 30 hydrocarbon groups substituted by groups; R 1 is one of the C 1 -C 30 hydrocarbon groups that are saturated or unsaturated, straight or branched, heteroatom-containing or non-heteroatom-free; m is an integer greater than or equal to 2; when m=2, compound 2 is, H 2 C=CH-SO 2 -OR 1 ; M in the M-containing reagent is one of NH 4 + and metal elements;化合物3的结构式为式III所示通式结构:The structural formula of compound 3 is the general structure shown in formula III:化合物4的结构式为式IV所示通式结构:The structural formula of compound 4 is the general structure shown in formula IV:
- 根据权利要求1所述的一种含磺酸基的化合物及其盐的制备工艺,其中,The preparation process of a kind of compound containing sulfonic acid group and salt thereof according to claim 1, wherein,化合物4中的Y为N-C mH 2m-SO 2-OH时,化合物1具有通式结构 的至少一种; When Y in compound 4 is NC m H 2m -SO 2 -OH, compound 1 has the general structure at least one of制备步骤S1中,化合物1与化合物2反应,制备得到通式结构为式V所示的化合物;In the preparation step S1, compound 1 is reacted with compound 2 to prepare a compound whose general structure is represented by formula V;式V所示通式结构为:The general structure shown in formula V is:制备步骤S2中,将通式结构为式V的化合物与含M试剂反应,得到通式结构为式VI的含磺酸基的化合物对应的盐粗品;经过酸化反应之后,得到通式结构为式VI的含磺酸基的化合物,或对应的水合物;In the preparation step S2, the compound with the general structure of formula V is reacted with the M-containing reagent to obtain the crude salt corresponding to the compound with the general structure of formula VI containing sulfonic acid groups; after the acidification reaction, the general structure is obtained as the formula A compound containing a sulfonic acid group of VI, or a corresponding hydrate;式VI所示通式结构为:The general structure shown in formula VI is:
- 根据权利要求1-2之一所述的一种含磺酸基的化合物及其盐的制备工艺,其中,The preparation process of a compound containing sulfonic acid groups and salts thereof according to any one of claims 1-2, wherein,含磺酸基的化合物4对应的含M盐,也包括含磺酸基的化合物4对应的含M盐的水合物;The M-containing salt corresponding to the compound 4 containing the sulfonic acid group also includes the hydrate of the M-containing salt corresponding to the compound 4 containing the sulfonic acid group;含磺酸基的化合物4,也包括含磺酸基的化合物4对应的水合物。The compound 4 containing a sulfonic acid group also includes the corresponding hydrate of the compound 4 containing a sulfonic acid group.
- 根据权利要求1-2之一所述的一种含磺酸基的化合物及其盐的制备工艺,其中,所述含磺酸基的化合物为哌嗪-N,N'-二(2-乙磺酸)、3-吗啉丙磺酸、4-羟乙基哌嗪乙磺酸、2-吗啉乙磺酸或所述哌嗪-N,N'-二(2-乙磺酸)、3-吗啉丙磺酸、4-羟乙基哌嗪乙磺酸、2-吗啉乙磺酸的钠盐中的一种。A preparation process for a compound containing a sulfonic acid group and a salt thereof according to any one of claims 1-2, wherein the compound containing a sulfonic acid group is piperazine-N,N'-bis(2-ethane sulfonic acid), 3-morpholinepropanesulfonic acid, 4-hydroxyethylpiperazineethanesulfonic acid, 2-morpholineethanesulfonic acid or the piperazine-N,N'-di(2-ethanesulfonic acid), One of the sodium salts of 3-morpholinepropanesulfonic acid, 4-hydroxyethylpiperazineethanesulfonic acid, and 2-morpholineethanesulfonic acid.
- 根据权利要求1-2之一所述的一种含磺酸基的化合物及其盐的制备工艺,其中,Y为NR时,R为末端被磺酸根、羟基、磺酸盐之一的基团取代的C 1-C 30烃基中的一种,Y为N-C mH 2m-SO 2-OH、N-C mH 2m-OH、N-C mH 2m-CO-OH。 A preparation process for a sulfonic acid group-containing compound and its salt according to any one of claims 1-2, wherein, when Y is NR, R is a group whose end is covered with one of sulfonate, hydroxyl, and sulfonate One of substituted C 1 -C 30 hydrocarbon groups, Y is NC m H 2m -SO 2 -OH, NC m H 2m -OH, NC m H 2m -CO-OH.
- 根据权利要求1-2之一所述的一种含磺酸基的化合物及其盐的制备工艺,其中,所述M试剂为含M单质、含M的碱、含M的氧化物、含M的盐或者它们的前驱体、复盐、水合物、溶剂络合物、卤化氢络合物中的一种或两种以上的组合物。The preparation process of a sulfonic acid group-containing compound and its salt according to any one of claims 1-2, wherein the M reagent is an M-containing element, an M-containing base, an M-containing oxide, or an M-containing salts or their precursors, double salts, hydrates, solvent complexes, hydrogen halide complexes, or a combination of two or more.
- 根据权利要求1-2之一所述的一种含磺酸基的化合物及其盐的制备工艺,其中,制备步骤S1中,反应温度为-50-200℃,反应压力为-0.05-1MPa,反应时间为0.1-72小时;制备步骤S2中,反应温度为-50-200℃,反应压力为-0.05-1MPa,反应时间为0.1-72小时。The preparation process of a sulfonic acid group-containing compound and its salt according to any one of claims 1-2, wherein, in the preparation step S1, the reaction temperature is -50-200°C, and the reaction pressure is -0.05-1MPa, The reaction time is 0.1-72 hours; in the preparation step S2, the reaction temperature is -50-200° C., the reaction pressure is -0.05-1 MPa, and the reaction time is 0.1-72 hours.
- 根据权利要求1-2之一所述的一种含磺酸基的化合物及其盐的制备工艺,其中,制备步骤S1中,化合物1与化合物2的摩尔比为1:(0.1-10);制备步骤S2中,化合物3与含M试剂的摩尔比为1:(0.1-10)。The preparation process of a compound containing a sulfonic acid group and its salt according to any one of claims 1-2, wherein, in the preparation step S1, the molar ratio of compound 1 to compound 2 is 1: (0.1-10); In the preparation step S2, the molar ratio of the compound 3 to the M-containing reagent is 1:(0.1-10).
- 根据权利要求1-2之一所述的一种含磺酸基的化合物及其盐的制备工艺,其中,制备步骤S1中,化合物1与化合物2在反应溶剂A中反应,所述反应溶 剂A为甲醇、乙醇、丙酮、四氢呋喃、乙酸乙酯、碳酸二甲酯、碳酸二乙酯、乙醚、乙腈、二氧六环、N,N-二甲基甲酰胺、二甲基亚砜中的至少一种;制备步骤S2中,化合物3与含M试剂在反应溶剂B中反应,所述反应溶剂B为甲醇、乙醇、丙酮、四氢呋喃、乙酸乙酯、碳酸二甲酯、碳酸二乙酯、乙醚、乙腈、二氧六环、N,N-二甲基甲酰胺、二甲基亚砜中的至少一种。The preparation process of a compound containing sulfonic acid group and its salt according to any one of claims 1-2, wherein, in the preparation step S1, compound 1 and compound 2 are reacted in reaction solvent A, and said reaction solvent A At least one of methanol, ethanol, acetone, tetrahydrofuran, ethyl acetate, dimethyl carbonate, diethyl carbonate, diethyl ether, acetonitrile, dioxane, N,N-dimethylformamide, dimethyl sulfoxide One; in the preparation step S2, the compound 3 reacts with the M-containing reagent in a reaction solvent B, and the reaction solvent B is methanol, ethanol, acetone, tetrahydrofuran, ethyl acetate, dimethyl carbonate, diethyl carbonate, ether , acetonitrile, dioxane, N,N-dimethylformamide, and dimethyl sulfoxide.
- 根据权利要求1-2之一所述的一种含磺酸基的化合物及其盐的制备工艺,其中,制备步骤S1中使用催化剂或助剂的至少一种进行反应。The preparation process of a sulfonic acid group-containing compound and its salt according to any one of claims 1-2, wherein, in the preparation step S1, at least one of a catalyst or an auxiliary agent is used for the reaction.
- 根据权利要求1-10之一所述的一种含磺酸基的化合物及其盐的制备工艺,其中,还包括如下制备步骤:The preparation process of a compound containing a sulfonic acid group and its salt according to any one of claims 1-10, wherein, further comprising the following preparation steps:在干燥条件下,使用干燥密闭设备或在干燥气体吹扫下,将制备步骤S2中所得粗品的含磺酸基的化合物,或者其盐,溶于纯化溶剂中,然后进行重结晶、过滤、干燥,得到精制的含磺酸基的化合物。Under dry conditions, using a dry airtight device or under dry gas purging, dissolve the crude product containing a sulfonic acid group, or its salt, in the purification solvent obtained in the preparation step S2, and then recrystallize, filter, and dry , to obtain refined compounds containing sulfonic acid groups.
- 根据权利要求11所述的一种含磺酸基的化合物及其盐的制备工艺,其中,所述纯化溶剂为甲醇、乙醇、丙酮、四氢呋喃、乙酸乙酯、碳酸二甲酯、碳酸二乙酯、乙醚、乙腈、二氧六环、N,N-二甲基甲酰胺、二甲基亚砜中的一种或两种以上的组合物。The preparation process of a compound containing sulfonic acid group and its salt according to claim 11, wherein the purification solvent is methanol, ethanol, acetone, tetrahydrofuran, ethyl acetate, dimethyl carbonate, diethyl carbonate , ether, acetonitrile, dioxane, N,N-dimethylformamide, dimethyl sulfoxide, or a combination of two or more.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202210106045.1A CN114591266A (en) | 2022-01-28 | 2022-01-28 | Preparation process of compound containing sulfonic group |
CN202210106045.1 | 2022-01-28 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2023142797A1 true WO2023142797A1 (en) | 2023-08-03 |
Family
ID=81804691
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/CN2022/140658 WO2023142797A1 (en) | 2022-01-28 | 2022-12-21 | Preparation process for sulfonic acid-containing compound |
Country Status (2)
Country | Link |
---|---|
CN (1) | CN114591266A (en) |
WO (1) | WO2023142797A1 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN114591266A (en) * | 2022-01-28 | 2022-06-07 | 苏州亚科科技股份有限公司 | Preparation process of compound containing sulfonic group |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20060089509A1 (en) * | 2003-09-16 | 2006-04-27 | Carroll Glenn T | Preparation of substituted alkanesulfonates from 2-hydroxyalkanesulfonates |
CN104803949A (en) * | 2015-05-19 | 2015-07-29 | 山东理工大学 | Method for preparing high-purity 4-hydroxyethyl piperazine ethane sulfonic acid |
CN109836399A (en) * | 2017-11-27 | 2019-06-04 | 荆楚理工学院 | A kind of synthetic method of biological buffer-morpholinoethanesulfonic acid |
CN110683995A (en) * | 2019-09-17 | 2020-01-14 | 苏州亚科科技股份有限公司 | Piperazine ethanesulfonic acid derivative preparation method |
CN114591266A (en) * | 2022-01-28 | 2022-06-07 | 苏州亚科科技股份有限公司 | Preparation process of compound containing sulfonic group |
-
2022
- 2022-01-28 CN CN202210106045.1A patent/CN114591266A/en active Pending
- 2022-12-21 WO PCT/CN2022/140658 patent/WO2023142797A1/en unknown
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20060089509A1 (en) * | 2003-09-16 | 2006-04-27 | Carroll Glenn T | Preparation of substituted alkanesulfonates from 2-hydroxyalkanesulfonates |
CN104803949A (en) * | 2015-05-19 | 2015-07-29 | 山东理工大学 | Method for preparing high-purity 4-hydroxyethyl piperazine ethane sulfonic acid |
CN109836399A (en) * | 2017-11-27 | 2019-06-04 | 荆楚理工学院 | A kind of synthetic method of biological buffer-morpholinoethanesulfonic acid |
CN110683995A (en) * | 2019-09-17 | 2020-01-14 | 苏州亚科科技股份有限公司 | Piperazine ethanesulfonic acid derivative preparation method |
CN114591266A (en) * | 2022-01-28 | 2022-06-07 | 苏州亚科科技股份有限公司 | Preparation process of compound containing sulfonic group |
Non-Patent Citations (1)
Title |
---|
CARLOS M. CRUZ; MARIANO ORTEGA‐MUÑOZ; F. JAVIER LÓPEZ‐JARAMILLO; FERNANDO HERNÁNDEZ‐MATEO; VICTOR BLANCO; FRANCISCO SANTOYO‐GONZÁL: "Vinyl Sulfonates: A Click Function for Coupling‐and‐Decoupling Chemistry and their Applications", ADVANCED SYNTHESIS AND CATALYSIS, JOHN WILEY & SONS, INC., HOBOKEN, USA, vol. 358, no. 21, 27 September 2016 (2016-09-27), Hoboken, USA, pages 3394 - 3413, XP072351897, ISSN: 1615-4150, DOI: 10.1002/adsc.201600628 * |
Also Published As
Publication number | Publication date |
---|---|
CN114591266A (en) | 2022-06-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2020024430A1 (en) | Preparation method for hydrogen bis(fluorosulfonyl)imide and lithium salt thereof | |
CA3103280A1 (en) | Method of preparing high chiral purity lactam intermediate and brivaracetam | |
WO2021082449A1 (en) | Preparation method for lithium fluorosulfate | |
WO2023142797A1 (en) | Preparation process for sulfonic acid-containing compound | |
CN111808034A (en) | Method for synthesizing 1,2, 4-triazole-3-methyl carboxylate | |
CN114014280A (en) | Preparation method of lithium bis (fluorosulfonyl) imide | |
CN113816858B (en) | Preparation method of trans-1, 2-diaminomethylcyclobutane and hydrochloride thereof | |
WO2023045601A1 (en) | Method for preparing tricine | |
CN112552336B (en) | Distearoyl phospholipid preparation method of acyl ethanolamine | |
CN111518156B (en) | One-step preparation method of astragaloside | |
CN112159388B (en) | Preparation method of vinyl sulfate derivative | |
WO2023039940A1 (en) | Method for preparing n,n,n-tripivaloyl-1,3,5-triaminobenzene | |
KR20240122544A (en) | Method for producing oxidized glutathione and its crystal form and impurities | |
CN112194585B (en) | Synthetic method of bromhexine hydrochloride | |
CN114920670B (en) | Preparation method of 5-chloro-2-aminobenzenesulfonamide | |
CN114671810A (en) | Preparation method of imidocarb | |
CN115466302B (en) | Synthesis and purification method of abiraterone acetate | |
CN107235873A (en) | A kind of preparation method of high-purity mesna | |
CN115536610B (en) | Preparation method of vothixetine | |
CN109535025B (en) | Preparation method of Evonib intermediate 3, 3-difluorocyclobutylamine hydrochloride | |
CN115448858B (en) | Efficient synthesis process of 2-chloroethyl sodium sulfonate | |
CN116514684B (en) | Preparation method of O-sulfo-L-tyrosine sodium salt | |
CN117466782A (en) | Preparation process of N, N-bis (2-hydroxyethyl) -2-aminoethanesulfonic acid | |
US4078085A (en) | 3-Aminomethyl-4-homoisotwistane and its salt and process for producing same | |
CN115925562A (en) | Preparation method of salbutamol sulfate |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 22923583 Country of ref document: EP Kind code of ref document: A1 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |